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ABSTRACT Enterovirusesinvadethehostbycrossingtheintestinalmucosa,whichislinedbypolarizedepithelium.Anumberof
enteroviruses,includingechoviruses(EV)andgroupBcoxsackieviruses(CVB),initiateinfectionbyattachingtodecay-
acceleratingfactor(DAF),amoleculethatishighlyexpressedontheapicalsurfaceofpolarizedepithelialcells.Wepreviously
observedthatentryofDAF-bindingCVB3intopolarizedintestinalepithelialcellsoccursbyanunusualendocyticmechanism
thatrequirescaveolinbutdoesnotinvolveclathrinordynamin.HereweexaminedtheentryofaDAF-bindingechovirus,EV7.
Wefoundthatdrugs,smallinterferingRNAs(siRNAs),anddominantnegativemutantsthattargetfactorsrequiredforclathrin-
mediatedendocytosis,includingclathrinanddynamin,inhibitedbothEV7infectionandinternalizationofvirionsfromthecell
surface.Oncevirushadenteredthecell,itcolocalizedwithmarkersofearlyendosomes(EEA1)andthenlateendosomes(LAMP-
2).Inhibitionofendosomalmaturation—withsiRNAsordominantnegativemutantstargetingRab5andRab7—inhibitedinfec-
tionandpreventedreleaseofviralRNAintothecell.TheseresultsindicatethatEV7isinternalizedbyclathrin-mediatedendocy-
tosisandthenmovestoearlyandlateendosomesbeforereleasingitsRNA.Trafﬁckingthroughendosomesisknowntobe
importantforvirusesthatdependonlowpHorendosomalcathepsinproteasestocompletetheentryprocess.However,we
foundthatEV7infectionrequiredneitherlowpHnorcathepsins.
IMPORTANCE Theresultsdemonstratethatechovirus7(EV7),afterbindingtodecay-acceleratingfactor(DAF)onthecellsur-
face,enterscellsbyclathrin-mediatedendocytosis;thisentrymechanismdiffersmarkedlyfromthatofanotherDAF-binding
enterovirus,coxsackievirusB3(CVB3).Thus,afterattachmenttothesamecellsurfacereceptor,thesecloselyrelatedvirusesen-
terthesamecellsbydifferentmechanisms.ThecellularcuesrequiredforreleaseofviralRNAfromtheenteroviruscapsid(“un-
coating”)remainpoorlydeﬁned.WefoundthatEV7movedtolateendosomesandthatreleaseofRNAdependedonendosomal
maturation;nonetheless,EV7didnotdependontheendosomalfactorsimplicatedinuncoatingandentrybyotherviruses.The
resultssuggesteitherthatanunidentiﬁedendosomalfactorisessentialforuncoatingofEV7orthattrafﬁckingthroughtheen-
dosomeisanessentialstepinapathwaythatleadstoanotherintracellularorganellewhereuncoatingiscompleted.
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E
choviruses (EV) and group B coxsackieviruses (CVB) are hu-
manpathogensbelongingtotheEnterovirusgenusofthefam-
ily Picornaviridae, as are polioviruses, some newer enteroviruses
(1), and human rhinoviruses (2). The 28 serotypes of EV and 6
serotypesofCVBarehumanpathogensthatcausefebrileillnesses,
meningitis,andmyocarditis(1).Theearliesteventsininfectionby
an enterovirus include attachment to a receptor on the cell sur-
face,internalizationofthevirionintothecell,anduncoating—the
release of the RNA genome from the capsid into the cytoplasm.
Together, these events comprise the process of viral entry (re-
viewed in references 3 and 4). Individual enteroviruses enter cells
by diverse mechanisms, employing different receptors, different
endocyticprocesses,anddifferentcuesforinitiationofuncoating;
further, a single virus may use different mechanisms to enter dif-
ferent types of cells (3).
Amongtheendocyticpathwaysinvolvedinvirusentry,thebest
studied is clathrin-mediated endocytosis, a process by which li-
gands and their receptors are internalized in clathrin-coated ves-
icles(5).Anotherimportantpathwayinvolvesuptakeincaveolae,
in which cholesterol-rich membrane domains (lipid rafts) are as-
sociated with the transmembrane protein caveolin (6). Both
clathrin-mediated and caveolar endocytosis depend on the activ-
ity of a large GTPase, dynamin-2, which promotes the release of
endocyticvesiclesfromtheplasmamembrane(7–9).Anumberof
clathrin- and caveolin-independent pathways have also been de-
scribed (reviewed in references 5 and 10). These less well-deﬁned
pathways have been classiﬁed according to their dependence on
speciﬁc cellular factors, such as lipid rafts, dynamin, ﬂotillin (a
protein with topology similar to that of caveolin), and the small
GTPase Arf6.
Oncethevirionhasbeeninternalized,thecriticaleventinentry
is delivery of the single-strand, positive-sense RNA to the cyto-
plasm, where replication occurs. The mechanisms of enterovirus
uncoatingareonlypartlyunderstood.Insomecases,contactwith
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capsid and begins the uncoating process. Such changes are ob-
served when poliovirus interacts with its receptor, PVR (11), or
when coxsackievirus B3 (CVB3) interacts with the coxsackievirus
and adenovirus receptor, CAR (12); the initial conformational
changes can be detected by altered sedimentation proﬁles in su-
crose gradients, with native virions sedimenting at 150S to 160S
and altered particles sedimenting at 135S. Rhinovirus capsids are
unstable at low pH, and for some rhinoviruses uncoating occurs
whenthevirionisdeliveredtoanacidicendosome(13).However,
most enteroviruses are transmitted by the fecal-oral route and
mustsurviveexposuretostomachacid;inconsequence,theircap-
sids are stable at low pH, and their uncoating appears to be inde-
pendent of endosomal acidiﬁcation.
Enteroviruses are thought to invade the host by crossing the
intestinalepithelium,whichislargelycomposedofpolarizedcells
with distinct apical and basolateral surfaces. Both CVB and many
echoviruses bind to decay-accelerating factor (DAF; CD55) (14–
17),acomplementregulatorymoleculethatishighlyexpressedon
the apical surface of polarized cells (18). We previously (19) ob-
served that, to infect polarized epithelium, CVB3 binds DAF on
the cell surface, moves to the tight junction, and then enters the
cell by an unusual mechanism that is independent of both dy-
naminandclathrinbutwhichrequirescaveolin;contactwithCAR
inthetightjunctionleadstoanessentialconformationalchangein
the CVB3 virion, but disruption of the capsid does not appear to
occur until the virus has moved to an unidentiﬁed intracellular
compartment.
UnlikeCVB,DAF-bindingechovirusesdonotrequireCARfor
infection. To understand how these viruses gain access to polar-
ized epithelium, we have examined the entry of a DAF-binding
echovirus, EV7, into polarized intestinal epithelial cells. We ﬁnd
that EV7 is internalized by clathrin-mediated endocytosis and
moves to early and then to late endosomes early in infection. Al-
though uncoating does not require endosomal acidiﬁcation, it
dependsonnormalendosomalmaturation.Theseresultsindicate
that, although CVB3 and EV7 bind to the same cell surface recep-
tor, they enter cells by different endocytic mechanisms. Further,
although EV7 does not require low pH for uncoating, it must
nonetheless move to late endosomes before uncoating can occur.
RESULTS
EV7 infection of Caco-2 cells requires DAF. We ﬁrst conﬁrmed
that EV7 entry into Caco-2 cells depends on DAF. Caco-2 cells
were transfected with small interfering RNA (siRNA) targeting
DAF,controlsiRNA,orsiRNAtargetingCAR.Transfectedmono-
layers were exposed to EV7 or to CVB3-RD, a virus that depends
both on DAF and CAR for infection; the number of infected cells
was determined by staining for newly synthesized viral protein
(Fig.1A).DAFsiRNAinhibitedinfectionbybothEV7andCVB3-
RD;asexpected,CARsiRNAinhibitedinfectiononlybyCVB3.In
additional experiments (not shown), anti-DAF monoclonal anti-
body (MAb) IF7 inhibited binding of radiolabeled EV7 to Caco-2
cells and inhibited EV7 infection of Caco-2 cells. Thus, infection
of Caco-2 cells by EV7, like infection of HeLa cells (14), depends
on DAF.
EV7 infection depends on dynamin and clathrin. We had
previouslyobservedthatCVB3infectionofCaco-2cellsoccursby
a complex process that depends on caveolin but not dynamin-2,
appears to be independent of clathrin-mediated endocytosis, and
is inhibited by depletion of membrane cholesterol (19). Here, we
examined cellular factors required for EV7 infection, using siR-
NAs, dominant negative (DN) mutants, and drugs targeting
clathrin-speciﬁc endocytic mechanisms. We found that infection
by EV7, but not by CVB3, was inhibited by siRNA depletion of
both clathrin and dynamin (Fig. 1B), by dominant negative mu-
tants of dynamin2 and the clathrin adaptor protein Eps15
(Fig. 1C), and by chlorpromazine (Fig. 1D), an inhibitor of
clathrin-mediatedendocytosis(20).Dynasore,apharmacological
inhibitor of dynamin GTPase activity (21), also had a marked
inhibitory effect on EV7 infection (Fig. 1D). (A small but statisti-
callysigniﬁcanteffectonCVB3infectionbydynasoremaybenon-
speciﬁc, as no inhibition of CVB3 was seen with dominant nega-
tive dynamin or dynamin siRNA.) In contrast, depletion of
caveolin-1withsiRNA(Fig.1B),expressionofdominantnegative
caveolin (Fig. 1C), or treatment with the cholesterol-depleting
agent methyl-beta cyclodextrin (Fig. 1C), all of which inhibited
CVB3, had no effect on EV7 infection. These results indicate that
infectionbyEV7dependsonbothdynaminandclathrin,aswould
be expected if virus entry depends on clathrin-mediated endocy-
tosis.
EV7 entry depends on dynamin and clathrin. To determine
whetherclathrinanddynaminarerequiredforeventsupstreamof
RNA release, we employed the neutral red (NR) infectious center
assayforvirusuncoatingpreviouslyusedtostudypoliovirusentry
(22). When virus is grown in the presence of NR, the dye is con-
centrated within the capsid, in close proximity to the RNA ge-
nome. Exposure to light activates the dye, damages the RNA, and
rendersthevirusnoninfectious.However,onceuncoatinghasoc-
curred, the NR diffuses away from the RNA, so that exposure to
lightnolongerinhibitsinfection.Wefoundthatplaqueformation
by neutral red-labeled EV7 (NR-EV7) was markedly inhibited
when Caco-2 monolayers were exposed to light at 30 and 60 min
but that the majority of NR-EV7 became insensitive to light by
90 min (Fig. 2A). This result suggested that uncoating had largely
occurred by 90 min. To monitor requirements for uncoating, we
pretreatedCaco-2cellswithinhibitors,exposedthemtoNR-EV7,
andallowedinfectiontoproceedinthedarkfor90min.Cellswere
then exposed to light, harvested, replated on cell monolayers,
overlaid with agar, and incubated to permit the appearance of
infectious centers. To control for nonspeciﬁc effects of the inhib-
itors, parallel assays were performed in which the illumination
step was omitted. If an inhibitor prevents or signiﬁcantly delays
cellulareventsupstreamofRNArelease,weexpectittoreducethe
formation of infectious centers in illuminated, but not unillumi-
nated, cells.
In a group of preliminary experiments (not shown), we con-
ﬁrmed that the uncoating inhibitor R78206 reduced infectious
center formation speciﬁcally in illuminated cells, as had previ-
ously been shown for poliovirus (22). In contrast, brefeldin A,
which acts on virus replication at a postentry step, had no effect
eitherinilluminatedorunilluminatedcells.(Asexpected,R72806
acted to stabilize the EV7 capsid, preventing the conversion of
150S native virions to 135S altered particles in infected cells, and
had little or no effect on binding of radiolabeled EV7 to Caco-2
monolayers.)
Dynasore and chlorpromazine both signiﬁcantly reduced the
numberofinfectiouscentersafterlightexposure,withlittleinhib-
itory effect seen in nonilluminated samples (Fig. 2B and C). Sim-
ilarly, depletion of dynamin and clathrin heavy chain with siRNA
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samples. These results conﬁrm that dynamin and clathrin are re-
quired for events of infection that precede release of viral RNA
from the capsid.
To test whether clathrin and dynamin are required for inter-
nalizationofvirionsfromthevirussurfaceratherthanforanother
trafﬁcking event upstream of RNA release, we tested the effects of
chlorpromazine and dynasore on the internalization of EV7 viri-
ons directly conjugated to a red ﬂuorophore, AF594. Cells were
pretreated with drugs, exposed to EV7-AF594 at 4°C, and then
incubated at 37°C for 90 min to permit entry to occur. Cells were
then ﬁxed without permeabilization and stained with anti-VP1
antibody and ﬂuorescein isothiocyanate (FITC)-labeled second-
ary antibody (green) to detect virus still exposed on the cell sur-
face. In control cells treated with dimethyl sulfoxide (DMSO) ve-
hicle alone, red-labeled virus was seen to accumulate in
perinuclear vesicles inaccessible to the anti-VP1 antibody
(Fig. 2D). Similar results were seen in cells treated with the un-
coatinginhibitorR78206(Fig.2G).However,incellstreatedwith
dynasore, virus remained trapped at the cell surface, as indicated
bythecongruenceofredandgreenﬂuorescence(Fig.2E,yellow).
In cells treated with chlorpromazine, virus was similarly trapped
FIG 1 EV7 infection depends on DAF-, dynamin-, and clathrin-mediated endocytosis. (A) EV7 infection is inhibited by DAF siRNA. Left, Caco-2 cells were
transfectedwithsiRNAstargetingDAForCARorwithcontrolsiRNA(labeled“C”)andthenculturedaspolarizedmonolayersandexposedtoEV7orCVB3,as
described in Materials and Methods. Infected cells were counted after staining with anti-VP1 antibody, and nuclei were counted after staining with DAPI. For
each virus, results are shown as the percentages of cells infected, normalized to the result with control siRNA, standard deviations (SD) for triplicate samples.
Right, immunoblot to conﬁrm depletion of CAR and DAF by siRNA. (B) EV7 infection is inhibited by siRNAs targeting dynamin 2 (dyne 2) and clathrin heavy
chain (CHC) but not by siRNA targeting caveolin 1 (Cav1). (C) EV7 infection is inhibited by dominant negative forms of dynamin 2 and Eps15 but not by
dominantnegativecaveolin1.PolarizedmonolayersofcellstransfectedwithGFP-taggedwild-typeordominantnegativedynamin2,Eps15,andcaveolin1were
exposedtoEV7orCVB3.InfectedGFP-expressingcellswerecountedafterbeingstainedwithanti-VP1antibody.Notshown,wild-typeGFP-dynamin2hadno
effectoninfection(comparedtoGFPalone).(D)EV7infectionisinhibitedbydynasoreandchlorpromazine(CPZ)butnotbymetyl-beta-cyclodextrin(MCD).
Results are normalized to those obtained for control cells exposed to DMSO carrier alone. In all panels, single asterisks indicate P values of 0.05, and double
asterisks indicate P values of 0.01.
EV7 Entry into Polarized Cells
March/April 2012 Volume 3 Issue 2 e00304-11
® mbio.asm.org 3atthecellsurface(Fig.2F).Takentogetherwiththedatapresented
above, these results indicate that EV7 entry and infection depend
on internalization of virions by clathrin-mediated endocytosis.
TheresultwithR78206indicatesthatconversionofnativevirions
to altered particles is not required for internalization of virions
into the cell.
Rab5 and Rab7 are important for infection and entry. Car-
goes internalized by clathrin-mediated endocytosis move rapidly
to early endosomes in the cell periphery and then to more central
late endosomes and lysosomes. Endosomal maturation is accom-
panied by changes in lipid and protein content, as well as by pro-
gressive acidiﬁcation (23). Two small GTPases, Rab5 and Rab7,
are critical for vesicular trafﬁc through the endosomal system:
Rab5 controls the delivery of cargoes to the early endosome,
whereas Rab7 regulates the maturation of late endosomes and
endosome-lysosome fusion (24). To begin to characterize the in-
FIG 2 EV7 entry depends on clathrin-mediated endocytosis. (A) Most neutral red-labeled virus becomes insensitive to light by 90 min postinfection. NR-EV7
was bound to Caco-2 monolayers at 4°C, unbound virus was washed off, and then monolayers were overlaid with agar and incubated at 37°C. At intervals,
monolayers were exposed to light and then incubated further to permit plaques to develop. (B) RNA release depends on dynamin. Neutral red infectious center
assayswereperformedwithcellspretreatedwithdynasoreinDMSO(labeled“Dyna”)orwithdynamin2(Dyn2)siRNA,asdescribedinMaterialsandMethods.
ResultsarenormalizedtothoseobtainedwithnonilluminatedcontrolsexposedtoDMSOornegative-controlsiRNA(labeled“C”).(C)RNAreleasedependson
clathrin-mediated endocytosis. Neutral red infectious center assay performed with cells pretreated with chlorpromazine (CPZ; compared to untreated control
cells) with clathrin heavy chain siRNA (CHC; compared to cells treated with control siRNA). (D) Cells exposed to red-labeled EV7 for 90 minutes were stained,
without permeabilization, with anti-VP1 antibody and with FITC-labeled secondary antibody, to detect virus on the cell surface. Virus (red) is internalized and
localizedtoperinuclearandothercytoplasmicvesicles.(E)Cellstreatedwithdynasore;treatedasdescribedforpanelC.Virusremainslargelyonthecellsurface,
asindicatedbygreenandyellowsignals.(F)Cellstreatedwithchlorpromazine.Virusremainslargelyonthecellsurface,asindicatedbygreenandyellowsignals.
(G) Cells treated with R78206.
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whether Rab5 and Rab7 were required for virus infection.
siRNAs targeting both Rab5 and Rab7 (Fig. 3A), as well as
dominant negative forms of Rab5 and Rab7 (Fig. 3B), inhibited
EV7 infection of Caco-2 cells. As previously reported (25), infec-
tion by CVB3-RD was inhibited by reagents targeting Rab5 but
not Rab7. These results suggested that EV7 might be delivered to
lateendosomesduringtheentryprocess.Totestthis,weexamined
the colocalization of EV7 with the early endosomal marker EEA1
(Fig. 4A and B) and the late endosomal marker LAMP-2 (Fig. 5A
and B) at intervals after infection. Colocalization with EEA1 in-
creased steadily until 60 min after infection (Fig. 4B) and then
decreased; colocalization with LAMP-2 increased more slowly
(Fig. 5B), reaching its maximum at 90 min after infection. These
results suggest that EV7 is delivered ﬁrst to early endosomes and
then to late endosomes.
In the neutral red uncoating assay, siRNAs targeting either
Rab5 or Rab7 inhibited infectious center formation after light ex-
posure, with little inhibitory effect seen in nonilluminated sam-
ples (Fig. 3C). Thus, both Rab5 and Rab7 are required for events
that occur upstream of RNA release. Taken together, these results
indicate that EV7 is delivered to late endosomes before uncoating
occurs.
EV7 uncoating does not require endosomal acidiﬁcation or
cathepsin activity. For a number of viruses, acidiﬁcation of the
endosome provides an important trigger for structural changes
that permit fusion of viral and endosomal membranes or release
of nucleic acid from the protein capsid. For some, the relatively
mild acidity of early endosomes is insufﬁcient, and delivery to
moreacidiclateendosomesisrequiredbeforeentrycanoccur(13,
26). Enteroviruses such as echovirus 7, which enter the body by
way of the intestine, must survive exposure to gastric acid and are
generallyquiteresistanttolowpH(27).TotestwhetherEV7entry
depends on the low pH of the late endosome, we used two agents
that prevent endosomal acidiﬁcation by different mechanisms,
ammoniumchloride(28)andtheendosomalprotonpumpinhib-
itor baﬁlomycin A (29). Neither ammonium chloride nor baﬁlo-
mycin inhibited EV7 infection of Caco-2 cells (Fig. 6A), although
both agents effectively blocked infection by vesicular stomatitis
virus, a virus that is known to require endosomal acidiﬁcation for
fusion and entry (30).
In addition to providing an acidic environment, endosomes
are rich in proteases; endosomal cysteine proteases (primarily
cathepsins L and B) have been shown to be important for a num-
berofviruses,includingreovirus(31),ebolavirus(32,33),murine
hepatitis virus 2 (34), and severe acute respiratory syndrome
(SARS) coronavirus (35). To examine the possible role of these
cathepsinsinentrybyEV7,wetreatedCaco-2cellswithinhibitors
of cathepsins B and L at concentrations known to inhibit entry by
reovirus (31). No effect on EV7 infection was detected (Fig. 6B),
despite signiﬁcant inhibition of cathepsin B and L activity in
treated cells (Fig. 6C and D). Similarly, the protease inhibitor
FIG 3 EV7 infection and RNA release depend on Rab5 and Rab7. (A) Left, infection is inhibited by siRNAs targeting Rab5 (pooled siRNAs targeting Rab5a,
Rab5b, and Rab5c) and Rab7 (single siRNA). Right, depletion of Rab5 and Rab 7 protein. (B) Infection is inhibited by dominant negative Rab5 and Rab7 (WT,
wildtype;D/N,dominantnegative).Notshown,wild-typeGFP-Rab5and-Rab7hadnoeffectoninfection(comparedtoGFPalone).(C)RNArelease.Neutral
red infectious center assays performed in cells pretreated with siRNAs targeting Rab5a, -5b, -5c, and -7, compared to results for cells pretreated with negative-
control siRNA.
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cathepsins B and L, had no effect on EV7 infection (data not
shown). Thus, EV7 entry requires virus trafﬁcking to late endo-
somes but does not depend on endosomal acidiﬁcation or the
activity of the major endosomal cathepsins.
DISCUSSION
The results we report here indicate that EV7, after binding to
DAF on the apical surface of polarized epithelial cells, is internal-
ized by clathrin-mediated endocytosis and then moves to early
and late endosomes before releasing its RNA into the cell. Drugs,
siRNAs, and dominant negative mutants that perturb clathrin-
mediated endocytosis were found to inhibit both EV7 infection
and internalization of virions from the cell surface. Internalized
virions were seen to colocalize with early and late endosomal
markers, and siRNAs and dominant negative mutants targeting
Rab GTPases essential for endosomal maturation inhibited infec-
tion, acting upstream of RNA release.
Like EV7, CVB3 also initiates infection of Caco-2 cells by at-
taching to DAF. However, the two viruses use different mecha-
nisms for entry. CVB3 entry requires virus interaction with CAR,
aproteinlocalizedspeciﬁcallytotightjunctions,andoccursbyan
unusual dynamin-independent mechanism that depends on
membrane cholesterol, phosphorylation of caveolin (19), and the
internalizationofthetightjunctionproteinoccludin(25),among
other factors. In contrast, EV7 internalization depends on host
factors associated with clathrin-mediated endocytosis.
Introduction of isolated enteroviral RNA into the cell cyto-
plasm is sufﬁcient to initiate infection. Thus, the critical event in
entry is the release of viral RNA from the capsid to the cytoplasm.
How this occurs is not well understood. For poliovirus, the ﬁrst
step in uncoating is triggered when the virion interacts with its
receptor, PVR: the virion undergoes a conformational change,
leading to exposure of previously buried hydrophobic peptides
and release from the capsid of a small internal protein, VP4. But
the resulting altered virion, referred to as the A particle, still re-
tains the RNA genome. A second conformational change, and
possibly an intracellular cue, is required for the genome to exit,
leaving behind a second identiﬁable altered virion, the 80S empty
capsid (4). In contrast to poliovirus interactions with PVR, some
viruses are not converted to A particles when they contact their
receptors. The receptor for minor-group rhinoviruses, the LDL
receptor, does not induce conformational changes but instead
mediates the delivery of these acid-susceptible viruses to endo-
somes, where uncoating is initiated by acidiﬁcation (13, 36).
CVB3 is converted to A particles during infection, but A particles
arenotformedwhenvirusbindstoDAF;conversiontoAparticles
andproductiveinfectionbothdependoninteractionwithanother
receptor, CAR (12, 37).
Although EV7 binds to human DAF on transfected rodent
FIG 4 EV7 moves to early endosomes by 60 minutes. (A) Cells were exposed to red-labeled EV7 for the indicated times and then ﬁxed, permeabilized, and
stained to detect the early endosomal marker EEA1 (green). (B) Colocalization between intracellular virus and EEA1, expressed as Pearson’s coefﬁcient,
measured for individual cells, with mean values shown in red.
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RNA into the same cells results in infection (our unpublished
data), suggesting that the block to infection occurs upstream of
RNA release. Like CVB3, EV7 has been noted to form A particles
during infection, but it is not converted to A particles when it is
exposedtosolubleformsofDAF;ithasthusbeensuggestedthata
secondcellularfactormaybeessentialforinfection(38).Whether
this factor is a second receptor protein or an intracellular cue of
another sort is uncertain.
The intracellular site where uncoating occurs also remains in
question. Direct visualization of RNA release has established that
poliovirus uncoating in HeLa cells occurs rapidly and quite close
to the plasma membrane (22). In contrast, indirect evidence sug-
gests that, in endothelial cells, poliovirus uncoating is completed
slowly, after virus has moved to a perinuclear compartment (39);
CVB3 uncoating in Caco-2 cells, as determined by appearance of
80S particles, also occurs deep within the cell (19). We found that
EV7uncoating,asdeﬁnedbytheneutralredassay,wascompleted
atapproximately90min,whenviruscolocalizationwithLAMP-2
was maximal. The requirement for Rab7 indicates that EV7 un-
coating depends on endosomal maturation, and it suggests that
the late endosomal environment may provide a signal important
for RNA release. Acidiﬁcation itself does not seem to be impor-
tant, as baﬁlomycin and ammonium chloride had no effect on
infection; further, although endosomal cathepsins are important
forentryofseveralviruses,infectionwasnotaffectedbyinhibition
of cathepsin activity. Ebolavirus entry was recently shown to de-
pend on the Niemann-Pick C1 protein (40, 41), a cholesterol
transport protein resident in late endosomes (42). We observed
no effect on EV7 infection when Caco-2 cells were treated with
U18666A (data not shown), an inhibitor of cholesterol synthesis,
which induces a cellular phenotype similar to that seen in
Niemann-Pick C1 deﬁciency and which has been shown to block
Ebola virus entry (40). Thus, if a speciﬁc endosomal factor is re-
quired for EV7 uncoating, it remains to be identiﬁed.
The observation that EV7 must reach late endosomes before
uncoating is unexpected for an enterovirus that does not depend on
endosomal acidiﬁcation. Our data do not show directly that uncoat-
ing occurs in the late endosome itself, and we cannot exclude the
possibility that trafﬁcking through the endosome is an essential step
in a pathway that leads to another intracellular organelle where un-
coating is completed; such is the case with SV40, which moves
through endosomes on its way to the endoplasmic reticulum (ER),
where destabilization of the capsid is catalyzed by factors present in
theERlumen(43,44).WearecurrentlyexploringwhetherEV7entry
dependsonadditionalhostfactorsassociatedwithspeciﬁcaspectsof
endosomal maturation or with trafﬁcking between late endosomes
and other intracellular compartments.
MATERIALS AND METHODS
Cells and viruses. Caco-2 cells (ATCC HTB-37) were cultured in high
glucose minimal essential medium containing 20% fetal bovine serum,
FIG5 EV7movestolateendosomesby90minutes.(A)Cellswereexposedtored-labeledEV7fortheindicatedtimesandthenﬁxed,permeabilized,andstained
todetectthelateendosomalmarkerLAMP-2(green).Arrowsindicateseveralsitesofcolocalization.(B)ColocalizationbetweenintracellularvirusandLAMP-2,
expressed as Pearson’s coefﬁcient, measured for individual cells, with mean values shown in red.
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ster ovary (CHO) cells stably transfected with cDNA encoding human
CAR, human DAF, or empty vector have been described previously (45).
Echovirus 7 (Wallace; ATCC VR-37) and CVB3-RD (19) were pre-
pared in HeLa cells, concentrated by ultracentrifugation through a su-
crosecushion,andtiteredbyplaqueassayonHeLacells.Vesicularstoma-
titis virus, provided by Ron Harty (University of Pennsylvania), was
prepared and the titer was determined in BHK-21 cells as described (46).
Antibodies and chemicals. CAR-speciﬁc rabbit polyclonal antibody
(H-300) and horseradish peroxidase (HRP)-conjugated GAPDH anti-
body (catalog no. sc-25778) were obtained from Santa Cruz Biotechnol-
ogy. Murine monoclonal antibodies speciﬁc for DAF (catalog no.
555691),clathrinheavychain(catalogno.610499),caveolin1(catalogno.
610406), and anti-EEA1 antibody (catalog no. 610457) were obtained
from BD. Rabbit polyclonal antibody speciﬁc for dynamin 2 was from
Abcam(catalogno.ab3457),rabbitpolyclonalanti-Rab5wasfromStress-
gen (catalog no. KAP-GP006), and rabbit polyclonal anti-Rab7 was from
Sigma (catalog no. R4479). Murine monoclonal antibody speciﬁc for
LAMP-2 (clone H4B4) was from the Developmental Studies Hybridoma
Bank at the University of Iowa, and monoclonal antibody speciﬁc for
vesicular stomatitis virus (VSV) M protein (clone 23H12) was obtained
from Douglas Lyles (Wake Forest University).
Dynasore,baﬁlomycinA1,cathepsinBinhibitor(catalogno.205531),
and cathepsin L inhibitor (catalog no. 219427) were obtained from Cal-
biochem. Chlorpromazine (CPZ), methyl-beta-cyclodextrin (MCD),
and NH4Cl were from Sigma. Compound R78206 was provided by Jans-
sen Pharmaceuticals.
Plasmids and siRNAs. Plasmids encoding green ﬂuorescent protein
(GFP)-tagged wild-type (WT) and K44A dominant negative (DN) dy-
namin 2 (47) were provided by Mark McNiven (Mayo Institute, Roches-
ter, MS); GFP-tagged WT and Y14F DN caveolin (48) were from Ari
Helenius(SwissFederalInstituteofTechnology,Zurich);EPS15-GFPWT
and DN (49) were provided by Alice Dautry-Varsat (Institut Pasteur,
Paris). GFP-tagged WT and DN (S34N) Rab5 were provided by George
Bloom (University of Virginia), and WT and DN (T22N) Rab7 were pro-
vided by Craig Roy (Yale University). Transfection with plasmids was
performed using the Amaxa Nucleofector System (Lonza). Transfected
cells were plated at 1  105 cells/well in collagen-coated 8-well chamber
slides (BD) and used for virus infection after 2 days.
ControlandhumanCARsiRNAshavebeendescribedpreviously(50).
The sequence of DAF siRNA is 5= GUA CCA GGU GGC AUA UUA
UTT 3=. SiRNAs targeting dynamin 2 (M-004007-03), clathrin heavy
chain (M-004001-00), and caveolin-1 (M-003467-01) were purchased
from Dharmacon. Rab5 siRNAs (rab5A [5= AGG AAU CAG UGU UGU
AGU ATT 3=], rab5B [5= GAA AGU CAA GCC UGG UAU UTT 3=], and
rab5C [5= CAA UGA ACG UGA ACG AAA UTT 3=]) were synthesized
basedonsequencesinapreviousreport(51),andRab7siRNA(sc-29460)
was purchased from Santa Cruz. SiRNAs targeting Rab5 and Rab7 were
used at a 20 nM concentration; other siRNAs were used at 100 nM.
Transfection was performed with Lipofectamine 2000 (Invitrogen).
Cells were transfected in 6-well plates; to optimize the knockdown efﬁ-
ciency, a second transfection was performed 24 h after the ﬁrst. After an
additional24h,themonolayersweretrypsinizedandcellswerereplatedat
5  104 cells/well in collagen-coated 8-well chamber slides (BD Biosci-
ences), and infections were performed 2 days later. Depletion of targeted
proteins was conﬁrmed by immunoblot analysis of parallel samples.
Virus infection and internalization. Caco-2 cells were plated on
collagen-coated 8-well chamber slides (BD Biosciences) at 5  104 cells
FIG 6 EV7 infection does not depend on endosomal acidiﬁcation, acid protease, or cathepsin activity. (A) Endosomal acidiﬁcation. Cells were treated with
baﬁlomycin A1 (in DMSO) or to ammonium chloride and then exposed to EV7 or VSV. Infected cells were detected with anti-VP1 or anti-VSV antibody as
described in Materials and Methods. (B) Cathepsins. Cells were treated with inhibitors of cathepsin B (Cat Bi) or cathepsin L (Cat Li) and then exposed to EV7.
(C) Cathepsin B activity (in arbitrary units of ﬂuorescence) in cells treated with inhibitors; the negative-control reaction included no ﬂuorescent substrate. (D)
Cathepsin L activity in cells treated with inhibitors.
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CVB3-RD, or VSV; 2 PFU/cell) in minimum essential medium (MEM)
with20mMHEPESwaspermittedtobindtopolarizedmonolayersfor1h
at 4°C. Monolayers were then washed with phosphate-buffered saline
(PBS), complete medium was added, and cells were incubated for6ha t
37°C.Infectionwasterminatedbyﬁxationandpermeabilizationfor2min
with a 3:1 mixture of ice-cold methanol-acetone. Monolayers were
stained with anti-VP1 antibody (Ncl-Entero; Novocastra) to detect in-
fectedcellsandwith4’,6-diamidino-2-phenylindole(DAPI)todetectcell
nuclei, and images were captured with an Olympus BX51 immunoﬂuo-
rescence microscope, using a 20 objective. Three or four ﬁelds (700 to
1,000 cells) were captured for each monolayer. The numbers of infected
cells and the total number of DAPI-stained nuclei were quantiﬁed using
ImageJ software (http://rsbweb.nih.gov/ij/).
For entry staining, EV7, puriﬁed on sucrose gradients, was labeled
with a 10-fold molar excess of AlexaFluor 594 (AF-594) succinamidyl
ester (Molecular Probes), using a protocol previously described for label-
ingEV1.AF594-EV7(300PFU/cell)wasallowedtobindtocellsfor1hat
4°C at 300 PFU/cell. After a PBS wash, complete medium was added and
cellswereincubatedfor90minat37°C.Virusinternalizationwasstopped
by ﬁxation with 4% paraformaldehyde (PFA) for 12 min, and excess PFA
was removed with PBS containing 50 mM NH4Cl. Surface-associated vi-
rus was detected by staining unpermeabilized monolayers with anti-VP1
antibody and anti-mouse secondary antibody conjugated to FITC. Slides
were mounted with Vectashield (Vector Laboratories). Images were cap-
turedwithaZeissLSM510confocalmicroscopeusinga63oilobjective.
Z-stack images were obtained at 0.6-m intervals and viewed with the
LSM Reader plugin for ImageJ.
Inhibitory drugs were used at the following concentrations: dynasore,
120M;baﬁlomycinA1,10nM;cathepsinBinhibitor,10M;cathepsin
L inhibitor, 10 M; chlorpromazine, 10 g/ml; MCD, 5 mM; NH4Cl,
10 mM; brefeldin A, 10 g/ml; R78206, 10 g/ml. In general (see excep-
tionsbelow),cellswerepretreatedfor60minat37°Cincompletemedium
containing the drug, and then virus was permitted to bind in drug-
containingmediumat4°Cfor1h.Unboundviruswasremoved,andthen
drug-containing medium was replaced and infection was allowed to pro-
ceed at 37°C for 6 h.
ForexperimentswithdynasoreandMCD,mediumwith20%NuSe-
rum (BD Biosciences, Bedford, MA) in place of fetal bovine serum (FBS)
was used, because serum components can decrease the efﬁcacy of those
drugs (23). In experiments with dynasore, drug-containing medium was
replaced with normal medium after 3 h. Because MCD acts quickly to
depletecholesterolfromtheplasmamembrane,cellswerepretreatedwith
MCD for 45 min and drug was not used again during the course of
infection.
Neutral red infectious center assay (uncoating assay). To prepare
neutral red (NR)-labeled virus (NR-EV7), HeLa cells were infected with
EV7 (10 PFU/cell) in the presence of 10 g/ml NR. After overnight incu-
bation, virus was harvested and puriﬁed in the dark.
Neutral red infectious center assays using inhibitor drugs or siRNAs
were performed as described by Brandenburg et al. (22) with slight mod-
iﬁcations. In experiments with siRNAs, Caco-2 cells were transfected and
allowed to form polarized monolayers in 12-well plates before infection.
In experiments with drugs, monolayers in 12-well plates were pretreated
with a drug for1ha t37°C. In the dark, NR-EV7, in binding buffer
containing the drug, was allowed to attach to cells at 4°C for 1 h; binding
buffer was then removed and infection was initiated by adding warmed
culturemedium,containingthedrugifappropriate.After90minat37°C,
virus-infected cells were exposed to white light for 10 min at room tem-
perature; preliminary experiments indicated that a 90-min incubation
was required for the majority of input virus to escape light-induced NR
damage. Duplicate monolayers were maintained in the dark and used as
unilluminatedcontrols.Cellsweredetachedwithtrypsin-EDTAandthen
counted, diluted, and replated onto fresh Caco-2 monolayers in 6-well
plates, in the absence of inhibitors. Agarose overlay was added after 3 h.
After 2 days, plaques were developed and counted. In each of four inde-
pendent experiments, the numbers of plaques in the drug-treated or illu-
minatedwellswerenormalizedtothenumberofplaquesintheunillumi-
nated control well (expressed as a percentage). Therefore, no error
estimates are provided for the controls, which were deﬁned as 100%.
Capsidconformationalchanges.Conversionofnativevirionsto135S
Aparticleswasdetectedessentiallyasdescribedinreference12.Monolay-
ers were incubated with radiolabeled EV7 at 4°C, unbound virus was
removed, and cells were either maintained in the cold or incubated at
37°C,eitherinthepresenceofR78206orinDMSOalone.At90min,cells
were lysed, debris was removed, and recovered virus was subjected to
centrifugation in 15 to 35% sucrose gradients.
Colocalization with endosomal markers. Caco-2 monolayers were
incubatedwithAF594-EV7at37°C.At15-minintervals,monolayerswere
ﬁxed with a 3:1 mixture of ice-cold methanol-acetone and stained with
antibodies speciﬁc for EEA-1 or LAMP-2 followed by FITC-conjugated
secondary antibody and examined by confocal microscopy. Images with
the best focus in the red (virus) channel were captured and analyzed. To
exclude noninternalized virus, the cytoplasmic region of each cell was
outlined with the freehand selection tool of ImageJ. Colocalization of red
and green signal was determined, using the colocalization Test plugin in
theWCIFImageJbundletocalculatePearson’scorrelationcoefﬁcientfor
eachcell.Threeindependentexperimentswereperformed.Ineachexper-
iment, at least ﬁve images were analyzed for each time point.
Measurement of cathepsin B and L activity. Cathepsin activity was
measured as described by Ebert et al. (31) with slight modiﬁcations.
Caco-2 cells were preincubated with cathepsin B or L inhibitor (10 M)
for 1 h and washed with PBS and lysed with 100 mM sodium acetate
(pH 5), 1 mM EDTA, and 0.5% Triton X-100. Insoluble debris was re-
moved, and cell lysate was mixed with cathepsin B substrate (100 M;
Calbiochem catalog no. 219392) and incubated for 30 min at room tem-
perature or with cathepsin L substrate (50 M; Invitrogen catalog no.
R6502) and incubated for 1.5 h at 37°C. For cathepsin B activity, ﬂuores-
cencewasmeasuredusingaSynergy2multimodemicroplatereader(Bio-
Tek) with excitation at 390 nm and emission at 460 nm. For cathepsin L
activity,ﬂuorescencewasmeasuredusingaFLUOstarﬂuorometer(BMG
LabTechnologies) with excitation at 490 nm and emission at 520 nm.
Analysis of experimental variation. In all ﬁgures, error bars indicate
the means  standard deviations for 4 or more independent samples.
Single asterisks indicate P values of 0.05, as determined by Student’s
t test; double asterisks indicate P values of 0.01.
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